港股异动 | 百威亚太逆势涨逾4% 即将获纳入恒生综合指数
格隆汇10月2日丨百威亚太(1876.HK)继上市首日涨4.4%后,于今日至现价29.4港元再度上涨4.26%,暂成交11.59亿港元,最新总市值3893亿港元。恒指公司9月30日表示,将于2019年10月15日(星期二)收市后将百威亚太纳入恒生综合指数及恒生消费品制造及服务业指数,10月16日起生效。公司是亚太地区最大且快速成长的啤酒公司,2017年、2018年收益分别为60.99亿、67.4亿美元,溢利为5.72亿、9.59亿美元,2018历史市盈率为47至52.22倍。其执行董事杨克称,司在亚洲市场有很好表现,而亚洲市场是全球最大的啤酒消费市场,相信未来公司会有出色表现。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.